Chinese Journal of Pharmacovigilance ›› 2021, Vol. 18 ›› Issue (10): 915-919.
DOI: 10.19803/j.1672-8629.2021.10.04
Previous Articles Next Articles
TIAN Di, MU Xuechun, CHEN Zhihai*
Received:
2021-05-06
Online:
2021-10-15
Published:
2021-10-27
CLC Number:
TIAN Di, MU Xuechun, CHEN Zhihai. Adjunctive Role and Prospects of Zinc Supplementation for Treatment of COVID-19[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 915-919.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2021.10.04
[1] Carlucci PM, Ahuja T, Petrilli C, et al.Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients[J]. J Med Microbiol, 2020, 69(10): 1228-1234. [2] Xing K, Tu XY, Liu M, et al.Efficacy and safety of COVID-19 vaccines: a systematic review[J]. Chinese Journal of Contemporary Pediatrics(中国当代儿科杂志), 2021, 23(3): 221-228. [3] Ren KR, Xu J, Dai JY, et al.Discussion on the potential medical value of Zinc in viral pneumonia[J]. Chinese Journal of Critical Care Medicine(中国急救医学), 2020, 40(10): 1020-1024. [4] Prasad AS, Bao B, Beck FW, et al.Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB[J]. Nutrition, 2011, 27(7-8): 816-823. [5] Shakoor H, Feehan J, Al Dhaheri AS, et al.Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?[J]. Maturitas, 2021, 143: 1-9. [6] Oyagbemi AA, Ajibade TO, Aboua YG, et al.Potential health benefits of zinc supplementation for the management of COVID-19 pandemic[J]. J Food Biochem, 2021, 45(2): e13604. [7] Bafaro E, Liu Y, Xu Y, et al. The emerging role of zinc transporters in cellular homeostasis and cancer[J/OL]. Signal Transduct Target Ther, (2017-07-28)[2021-04-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661630/. [8] Mayor-Ibarguren A, Busca-Arenzana C, Robles-Marhuenda. A hypothesis for the possible role of zinc in the immunological Pathways Related to COVID-19 Infection[J/OL]. Front Immunol, (2020-07-10)[2021-04-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365859/. [9] De Almeida Brasiel PG. The key role of zinc in elderly immunity: a possible approach in the COVID-19 crisis[J]. Clin Nutr ESPEN, 2020, 38: 65-66. [10] Yanagisawa H.Zinc deficiency and clinical practice-validity of zinc preparations[J]. Yakugaku Zasshi, 2008, 128(3): 333-339. [11] Prasad AS.Discovery of human zinc deficiency: its impact on human health and disease[J]. Adv Nutr, 2013, 4(2): 176-190. [12] Jarosz M, Olbert M, Wyszogrodzka G, et al.Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling[J]. Inflammopharmacology, 2017, 25(1): 11-24. [13] Gammoh NZ, Rink L.Zinc in infection and inflammation[J]. Nutrients, 2017, 9(6): 624. [14] Sharma P, Reddy PK, Kumar B.Trace element zinc, a nature's gift to fight unprecedented global pandemic COVID-19[J]. Biol Trace Elem Res, 2021, 199(9): 3213-3221. [15] Springer. Potential role of zinc in the COVID-19 disease process and its probable impact on reproduction [EB/OL].(2021-01-07)[2021-02-06]. https://link.springer.com/article/10.1007%2Fs43032-020-00400-6. [16] Marreiro DD, Cruz KJ, Morais JB,et al.Zinc and oxidative stress: current mechanisms[J]. Antioxidants (Basel), 2017, 6(2): 24. [17] Bonaventura P, Benedetti G, Albarède F, et al.Zinc and its role in immunity and inflammation[J]. Autoimmun Rev, 2015, 14(4): 277-285. [18] Ibs KH, Rink L.Zinc-altered immune function[J]. J Nutr, 2003, 133(5 Suppl 1): 1452S-1456S. [19] Wessels I, Haase H, Engelhardt G, et al.Zinc deficiency induces production of the proinflammatory cytokines IL-1β and TNFα in promyeloid cells via epigenetic and redox-dependent mechanisms[J]. J Nutr Biochem, 2013, 24(1): 289-297. [20] Te Velthuis AJ, Van den Worm SH, Sims AC, et al. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture[J]. PLoS Pathog, 2010, 6(11): e1001176. [21] Kaushik N, Subramani C, Anang S, et al.Zinc salts block hepatitis e virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase[J]. J Virol, 2017, 91(21): e00754-17. [22] Skalny AV, Rink L, Ajsuvakova OP, et al.Zinc and respiratory tract infections: Perspectives for COVID19 (Review)[J]. Int J Mol Med, 2020, 46(1): 17-26. [23] Katz E, Margalith E.Inhibition of vaccinia virus maturation by zinc chloride[J]. Antimicrob Agents Chemother, 1981, 19(2): 213-217. [24] Haraguchi Y, Sakurai H, Hussain S, et al.Inhibition of HIV-1 infection by zinc group metal compounds[J]. Antiviral Res, 1999, 43(2): 123-133. [25] National Heath Commission of the People's Republic of China. Diagnosis and treatment plan for COVID-19(trial version 8)[J]. Chinese Journal of Clinical Infectious Diseases(中华临床感染病杂志), 2020, 13(5): 321-328. [26] Hoffmann M, Kleine-Weber H, Schroeder S, et al.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2): 271-280. [27] Novick SG, Godfrey JC, Godfrey NJ, et al.How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action[J]. Med Hypotheses, 1996, 46(3): 295-302. [28] Solomon VR, Lee H.Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies[J]. Eur J Pharmacol, 2009, 625(1-3): 220-233. [29] Xue J, Moyer A, Peng B, et al.Chloroquine is a zinc ionophore[J]. PLoS One, 2014, 9(10): e109180. [30] Pormohammad A, Monych NK, Turner RJ.Zinc and SARS-CoV-2: a molec-ular modeling study of Zn interactions with RNA dependent RNA polymerase and 3C like proteinase enzymes[J]. Int J Mol Med, 2021, 47(1): 326-334. [31] Equils O, Lekaj K, Wu A, et al.Intra-nasal zinc level relationship to COVID-19 anosmia and type 1 interferon response: a proposal[J]. Laryngoscope Investig Otolaryngol, 2020, 6(1): 21-24. [32] Wessels I, Rolles B, Rink L.The potential impact of zinc supplem-entation on COVID-19 Pathogenesis[J/OL]. Front Immunol, [2020-07-10] [2021-04-30].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/. [33] Wadman M.Can interferons stop COVID-19 before it takes hold?[J]. Science, 2020, 369(6500): 125-126. [34] Prasad AS.Effects of zinc deficiency on Th1 and Th2 cytokine shifts[J]. J Infect Dis, 2000, 182(Suppl 1): S62-S68. [35] Komai M, Goto T, Suzuki H, et al.Zinc deficiency and taste dysfunction; contribution of carbonic anhydrase, a zinc-metalloenzyme, to normal taste sensation[J]. Biofactors, 2000, 12(1-4): 65-70. [36] Garnier-Crussard A, Forestier E, Gilbert T, et al.Novel coronavirus (COVID-19) epidemic: what are the risks for older patients?[J]. J Am Geriatr Soc, 2020, 68(5): 939-940. [37] DiSilvestro RA. Zinc in relation to diabetes and oxidative disease[J]. J Nutr, 2000, 130(5S Suppl): 1509S-1511S. [38] Sinha S, Sen S.Status of zinc and magnesium levels in type 2 diabetes mellitus and its relationship with glycemic status[J]. International Journal of Diabetes in Developing Countries, 2014, 34(4): 220-223. [39] Kazi TG, Afridi HI, Kazi N, et al.Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients[J]. Biol Trace Elem Res, 2008, 122(1): 1-18. [40] de Luis DA, Pacheco D, Izaola O, et al. Micronutrient status in morbidly obese women before bariatric surgery[J]. Surg Obes Relat Dis, 2013, 9(2): 323-327. [41] Suliburska J, Cofta S, Gajewska E, et al.The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents[J]. Eur Rev Med Pharmacol Sci, 2013, 17(17): 2396-2400. [42] Ennes DFF, De Sousa LVB, Mello S NR, et al.Biomarkers of metabolic syndrome and its relationship with the zinc nutritional status in obese women[J]. Nutr Hosp, 2011, 26(3): 650-654. [43] Błażewicz A, Klatka M, Astel A, et al.Differences in trace metal concentrations (Co, Cu, Fe, Mn, Zn, Cd, And Ni) in whole blood, plasma, and urine of obese and nonobese children[J]. Biol Trace Elem Res, 2013, 155(2): 190-200. [44] Costarelli L, Muti E, Malavolta M, et al.Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects[J]. J Nutr Biochem, 2010, 21(5): 432-437. [45] Voruganti VS, Cai G, Klohe DM, et al.Short-term weight loss in over-weight/obese low-income women improves plasma zinc and metabolic syndrome risk factors[J]. J Trace Elem Med Biol, 2010, 24(4): 271-276. [46] Payahoo L, Ostadrahimi A, Mobasseri M, et al.Effects of zinc supplemen-tation on the anthropometric measurements, lipid profiles and fasting blood glucose in the healthy obese adults[J]. Adv Pharm Bull, 2013, 3(1): 161-165. [47] Wang L, Song Y.Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: a meta-analysis of randomized, double-blind and placebo-controlled trials[J]. Clin Respir J, 2018, 12(3): 857-864. [48] Finzi E.Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients[J]. Int J Infect Dis, 2020, 99:307-309. [49] Jothimani D, Kailasam E, Danielraj S, et al.COVID-19: Poor outcom-es in patients with zinc deficiency[J/OL]. Int J Infect Dis, 2020, 100: 343-349. [50] Vogel-González M, Talló-Parra M, Herrera-Fernández V, et al.Low zinc levels at admission associates with poor clinical outcomes in SARS-CoV-2 Infection[J]. Nutrients, 2021, 13(2): 562. [51] Perera M, El Khoury J, Chinni V, et al.Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol[J]. BMJ Open, 2020, 10(12): e040580. [52] Yasui Y, Yasui H, Suzuki K, et al.Analysis of the predictive factors for a critical illness of COVID-19 during treatment-relationship between serum zinc level and critical illness of COVID-19[J]. Int J Infect Dis, 2020, 100:230-236. [53] Patel O, Chinni V, El-Khoury J, et al.A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients[J]. J Med Virol, 2021, 93(5): 3261-3267. |
[1] | ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan. Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58. |
[2] | LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan. Research status of cognitive dysfunction after SARS-CoV-2 infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64. |
[3] | MA Ruize, CHEN Zhihai. The latest progress of small molecule anti-SARS-CoV-2 drugs [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 961-966. |
[4] | LI Jing, XU Ye, LIU Ranjia, PAN Chen, CUI Xiangli. Adverse reactions in patients with COVID-19 after using tocilizumab [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1049-1053. |
[5] | YANG Qiuyue, SU Jun, ZHANG Xue, XIE Jiangan. Adverse events associated with the three US licensed COVID-19 vaccines based on VAERS database [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1141-1147. |
[6] | GE Ziruo, TIAN Di, WANG Aibin, ZHANG Tingyu, REN Xingxiang, QIAN Fang, LI Xingwang, CHEN Zhihai. Therapeutic effect of interferon atomization against COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 733-739. |
[7] | WANG Tiezhu. Signal detection and analysis of adverse reaction of hydroxychloroquine sulfate induced visual impairment [J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 657-660. |
[8] | ZHAO Xuan, GUO Jing, MEI Long, ZHANG Wei. Automatic dispensing system on influence of work efficiency of outpatient pharmacy and the safety of prevention and control of COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 564-567. |
[9] | YANG Fan, MA Haiping, YOU Mengru, LIAO Sha, LIU Lan, ZHU Jun. Applications of antiviral drugs in 456 patients with COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 413-416. |
[10] | ZHOU Boya, YUAN Sisi, FENG Xin. Research progress in effects of lopinavir / ritonavir used by lactating females on sucklings [J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 296-301. |
[11] | GUO Jun, REN Dan, YE Long, ZHAO Rongxiang, WANG Yu, YU Jing. Spontaneous muscular hemorrhage induced by warfarin tablets in a child [J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 339-341. |
[12] | XIONG Jing, LIU Yi, LIU Zhaoxia, LI Jie, ZHANG Caiyu, WU Xiangxiang, HE Lan. Development of the first national reference substance of ritonavir as a candidate drug against COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 137-141. |
[13] | LI Tianyu, JIA Yijiang, WANG Yuji, WANG Jinhui, LI Ye. Research progress of treatment drugs for SARS-CoV-2 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1266-1271. |
[14] | ZHAO Zhe, ZHANG Qing, GE Ziruo, ZHANG Wei, CHEN Zhihai. Giant progress in small molecule antiviral drugs for SARS-CoV-2 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 1-6. |
[15] | XIONG Jing, YAN Jing, LIU Yi, LIU Yang, HE Lan. Development of the first national reference substance of favipiravir as a candidate drug against COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 52-56. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||